in this study we compare the level of neurological disability longitudinally in a group of sspe patients receiving inosiplex ( isoprinosine ) treatment ( 12 ) to a historical control group of untreated patients ( 15 ) .
C0022230
inosiplex
C0795760
isoprinosine